Literature DB >> 32621774

The most common pediatric and adult dermatology patient complaints in a month of the COVID-19 pandemic in Turkey.

Ece Altun1.   

Abstract

Severe acute respiratory syndrome coronavirus 2 is the coronavirus strain that causes coronavirus disease 2019 (COVID-19). The World Health Organization (WHO) has designated the ongoing COVID-19 outbreak a Public Health Emergency of International Concern. WHO declared COVID-19 as a pandemic on 11 March 2020. During the pandemic and lockdown period, many dermatologic clinics were temporarily closed in Turkey as well as all over the world. Taking the necessary precautions, the hospital continued to examine all emergent and elective patients who applied to our dermatology clinic. We investigated the most common reasons for admission of pediatric and adult patients who were admitted to our outpatient clinic between 30 March and 30 April 2020, the period with the highest number of COVID-19 patients in Turkey. In children and adult age groups, the most common reason for admission was acne (N: 10 [16.4%] and N: 89 [20.9%], respectively). Of the 99 acne patients, 70 (70.7%) were using systemic isotretinoin and applied to our clinic to repeat the prescription or continue the agent. The number of pediatric patients admitted to the dermatology department drastically reduced during the lockdown period, which was attributed to the curfew for children in the country.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; acne; dermatology; pandemic

Mesh:

Substances:

Year:  2020        PMID: 32621774      PMCID: PMC7361077          DOI: 10.1111/dth.13972

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   3.858


INTRODUCTION

As of 31 December 2019, several cases of pneumonia of unknown etiology had been reported in Wuhan, Hubei Province, China. A new coronavirus pathogen was identified as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), and the SARS‐CoV‐2 infection outbreak was named coronavirus disease 2019 (COVID‐19) by the World Health Organization (WHO). On 11 March 2020, WHO declared a rapidly spreading novel coronavirus (COVID‐19) outbreak as a global pandemic. The main clinical symptoms are fever, headache, cough, and muscle pain. , More than 200 000 cases have been reported worldwide until mid‐March 2020. The new coronavirus was officially identified in Turkey for the first time on 11 March 2020. The Turkish government announced a curfew for people over the age of 65 years on 21 March 2020 and on 3 April 2020, for people under the age of 20 years. During the lockdown period, there was a reduction in the number of patients admitted to dermatology clinics in Turkey, as in every country. The aim of the current research was to provide epidemiologic data and management strategies for the patients admitted to the dermatology clinic during the COVID‐19 outbreak.

MATERIALS AND METHODS

Patients who directly applied to Medipol Mega University Hospital dermatology outpatient clinic between 30 March and 30 April 2020 were included in this retrospective study. Consultation patients and patients who applied to other clinics before our clinic were excluded from the study. The patients were divided into two groups: 0 to 17 years (pediatric population) and 18 years and older (adult population). The name, surname, age, gender, patient complaint, and medical history of the individuals included in the study were recorded and obtained from the hospital's computer‐based database. Clinical features, dermatologic features, treatment protocols, and follow‐up were investigated.

RESULTS

On average, a total of 3000 patients (500 children and 2500 adult patients) apply to our outpatient clinic monthly. Between 30 March and 30 April 2020, a total of 61 patients in the pediatric age group (30 boys and 31 girls) and a total of 425 patients in the adult age group (221 men and 204 women) applied to our outpatient clinic. The mean age of the patients in the pediatric age group was 8.4 ± 4.9 years (range: 1 month‐17 years) and in the adult age group was 34.4 ± 14 years (range: 18‐97 years). In total, 106 patients were already diagnosed and were on medical therapy. The reason for their admittance was the prescription of their medications. Sixty‐three of the 425 adult patients (14.8%) and seven of the 61 children (11.5%) were receiving systemic isotretinoin treatment for acne. Sixty‐six of the 425 adult patients had urticaria (15.5%) and 36 (8.5%) were receiving omalizumab treatment. The most common new‐onset diagnosed diseases in the pediatric age group were acne (N: 10, 16.4%), scabies (N: 4, 6.6%), atopic dermatitis (N: 5, 8.2%), other eczematous eruptions (N: 6, 9.8%), and diaper dermatitis (N: 4, 6.6%) (Table 1). The most common new‐onset diagnoses in the adult population were acne (N: 89, 20.9%), types of dermatitis (N: 64, 15.1%), superficial fungal infections (N: 36, 8.5%), urticaria (N: 66, 15.5%), and scabies (N: 28, 6.6%) (Table 2).
TABLE 1

Diseases of patients aged 17 years and younger who applied to the dermatology outpatient clinic

DiseaseNumber of patientsPercentage
Urticaria34.9
Acne1016.4
Superficial fungal infections34.9
Psoriasis11.6
Pruritus23.3
Telogen effluvium23.3
Verruca vulgaris23.3
Scabies46.6
Atopic dermatitis58.2
Diaper dermatitis46.6
Other eczematous eruptions69.8
Pityriasis rosea34.9
Bacterial infections46.6
Alopecia areata34.9
Zona zoster11.6
Herpes infections11.6
Infantile hemangioma11.6
Recurrent aphthous stomatitis11.6
Nail diseases23.3
Drug eruptions11.6
Varicella11.6
Molluscum contagiosum11.6
TABLE 2

Diseases of patients aged 18 years and older who applied to the dermatology outpatient clinic

DiseaseNumber of patientsPercentage
Urticaria6615.5
Acne8920.9
Superficial fungal infections368.5
Psoriasis143.3
Pruritus204.7
Telogen effluvium81.9
Verruca vulgaris112.6
Scabies286.6
Types of dermatitis6415.1
Vitiligo30.7
Pityriasis rosea92.1
Bacterial infections92.1
Alopecia areata40.9
Zona zoster112.6
Herpes infections61.4
Callus20.5
Syphilis30.7
Rosacea20.5
Hidradenitis suppurativa20.5
Androgenic alopecia20.5
Lichen planus20.5
Anogenital verruca40.9
Drug eruptions20.5
Recurrent aphthous stomatitis30.7
Melasma30.7
Autoimmune blistering disease20.5
Amyloidosis10.2
Actinic keratosis20.5
Nail diseases10.2
Cicatricial alopecia10.2
Malign melanoma10.2
Keloid scars10.2
Skin tags51.2
Pyogenic granuloma10.2
Molluscum contagiosum10.2
Xerosis20.5
Varicella20.5
Confluent and reticulated papillomatosis10.2
Thermal burn10.2
Diseases of patients aged 17 years and younger who applied to the dermatology outpatient clinic Diseases of patients aged 18 years and older who applied to the dermatology outpatient clinic

DISCUSSION

This article describes pediatric and adult patients admitted to a private university hospital's dermatology outpatient clinic in Istanbul, which was announced to be among the pandemic institutions in Turkey during the COVID‐19 outbreak. Turkey has many dermatology clinics that closed their doors temporarily in this period. Our dermatology clinic continued to take care of patients while taking all the necessary precautions. The number and percentage of pediatric patients admitted to the dermatology clinic during the pandemic period drastically reduced, which can be attributed to the curfew in the country. The total number of outpatients decreased by one‐sixth when compared with the number of admissions on a regular basis. According to our study, 63 of 89 adult patients with acne and seven of 10 pediatric patients with acne were receiving isotretinoin treatment, and these patients applied for the repetition of their prescription. A total of 36 of 66 adult patients with urticaria were receiving omalizumab treatment and applied to have the medicine prescribed. Only one of the patients receiving omalizumab had active lesions. Approximately, a quarter of the patients applied to our clinic during the 1‐month pandemic for the continuation of their medications. As previously indicated by Tan and Bhate, the prevalence of acne is 9.4%, but the rate was 23.3% in our study during the epidemic period. This rate was found to be 24.1% in the 1‐week pandemic period by Cengiz et al. Most of the patients who applied to our clinic did not have active lesions and applied to our hospital to have systemic isotretinoin prescribed. According to our study, 17 of 64 adult patients with dermatitis had rashes on their hands, and all of them had a history of frequent hand washing and disinfectant use. Intensive hand washing and disinfection usage can disrupt epidermal barrier functions and cause irritant contact dermatitis. Atopic diathesis, low humidity, increased frequency of handwashing, use of gloves, and working time are risk factors for the development and/or exacerbation of hand dermatitis. Three out of 14 psoriasis patients applied to have biologic agents prescribed. Our oldest patient was 97 years and applied to our clinic because of zona zoster infection. There is supporting evidence that stressful events may be a risk factor for patients with zona zoster infection. Cosmetic and nonurgent surgical procedures were not performed due to the risk of contamination. Patients with dermatologic diseases may increase the risk of developing infections, as diseases with epidermal barrier disruption can increase virus acquisition through indirect contact. Most of the patients wore masks. Doctors and other medical staff wore masks, gloves, and scrubs and used disinfectants. The use of a hygienic mask may not provide adequate protection from virus contamination, and COVID‐19 has a relatively low resistance to disinfectants. A range of disinfection options can be employed—varying from having a hot water bath at 56°C for 30 minutes to using 75% ethanol, chlorine, peracetic acid, and ultraviolet light disinfection.

CONCLUSION

In conclusion, patients with nonurgent needs continue to apply to the dermatology outpatient clinic despite the stay‐at‐home orders, the importance of social distancing, and a partial curfew. Children and adult patients were admitted to the dermatology outpatient clinic during the months of the COVID‐19 pandemic in Turkey compared to the period before the pandemic.
  10 in total

1.  Are stressful life events risk factors for herpes zoster?

Authors:  K Schmader; S Studenski; J MacMillan; S Grufferman; H J Cohen
Journal:  J Am Geriatr Soc       Date:  1990-11       Impact factor: 5.562

Review 2.  A global perspective on the epidemiology of acne.

Authors:  J K L Tan; K Bhate
Journal:  Br J Dermatol       Date:  2015-07       Impact factor: 9.302

3.  Dermatologic Manifestations of the 1918-1919 Influenza Pandemic.

Authors:  Jordan V Wang; Lawrence Charles Parish
Journal:  Skinmed       Date:  2019-09-01

4.  Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department.

Authors:  J Tao; Z Song; L Yang; C Huang; A Feng; X Man
Journal:  Br J Dermatol       Date:  2020-04-20       Impact factor: 9.302

5.  Cutaneous manifestations in COVID-19: a first perspective.

Authors:  S Recalcati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05       Impact factor: 6.166

6.  Which dermatology patients attend to Dermatology Outpatient Clinics during the SARS-CoV-2 outbreak in Turkey and what happened to them?

Authors:  Fatma Pelin Cengiz; Nazan Emiroglu; Anil Gulsel Bahali; Didem Dizman; Nazan Taslidere; Tahsin Cagdas Akarslan; Begum Gunes; Omer Mert; Ozlem Su Kucuk; Nahide Onsun
Journal:  Dermatol Ther       Date:  2020-05-11       Impact factor: 2.851

7.  COVID-19 pandemic and the skin: what should dermatologists know?

Authors:  Razvigor Darlenski; Nikolai Tsankov
Journal:  Clin Dermatol       Date:  2020-03-24       Impact factor: 3.541

8.  The most common pediatric and adult dermatology patient complaints in a month of the COVID-19 pandemic in Turkey.

Authors:  Ece Altun
Journal:  Dermatol Ther       Date:  2020-07-15       Impact factor: 3.858

9.  Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019.

Authors:  Yicen Yan; Hui Chen; Liuqing Chen; Bo Cheng; Ping Diao; Liyun Dong; Xinghua Gao; Heng Gu; Li He; Chao Ji; Hongzhong Jin; Wei Lai; Tiechi Lei; Li Li; Liuyi Li; Ruoyu Li; Dongxian Liu; Wei Liu; Qianjin Lu; Ying Shi; Jiquan Song; Juan Tao; Baoxi Wang; Gang Wang; Yan Wu; Leihong Xiang; Jun Xie; Jinhua Xu; Zhirong Yao; Furen Zhang; Jianzhong Zhang; Shaomin Zhong; Hengjin Li; Hang Li
Journal:  Dermatol Ther       Date:  2020-03-29       Impact factor: 2.851

10.  Skin damage among health care workers managing coronavirus disease-2019.

Authors:  Jiajia Lan; Zexing Song; Xiaoping Miao; Hang Li; Yan Li; Liyun Dong; Jing Yang; Xiangjie An; Yamin Zhang; Liu Yang; Nuoya Zhou; Liu Yang; Jun Li; JingJiang Cao; Jianxiu Wang; Juan Tao
Journal:  J Am Acad Dermatol       Date:  2020-03-18       Impact factor: 11.527

  10 in total
  1 in total

1.  The most common pediatric and adult dermatology patient complaints in a month of the COVID-19 pandemic in Turkey.

Authors:  Ece Altun
Journal:  Dermatol Ther       Date:  2020-07-15       Impact factor: 3.858

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.